GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international pharmaceutical and laboratory equipment supplier, grew dynamically in both divisions in fiscal 2016 according to its preliminary figures and achieved its financial targets raised at mid-year.
“The year 2016 was highly successful for Sartorius, both operationally and strategically,” commented CEO Dr. Joachim Kreuzburg. “Our Bioprocess Solutions Division is continuing to expand strongly.
